Peng Song
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 11
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 10
- Cancer Genomics and Diagnostics 8
-
- Lung Cancer Treatments and Mutations 30
- Lung Cancer Diagnosis and Treatment 13
- Ferroptosis and cancer prognosis 10
- Geriatrics and Gerontology top 10%
-
- RNA modifications and cancer 9
- Journals
- SHILAP Revista de lepidopterología (8 papers)PLoS ONE (1 paper)Biomaterials (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Peng Song
84 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Oncology 553
- Cancer Research 224
- Pulmonary and Respiratory Medicine 449
- Geriatrics and Gerontology 43
- Immunology 136
Countries citing papers authored by Peng Song
This map shows the geographic impact of Peng Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Song more than expected).
Fields of papers citing papers by Peng Song
This network shows the impact of papers produced by Peng Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Song. The network helps show where Peng Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 34 | |
| 6 | 2022 | 50 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 24 | |
| 12 | NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score | 2020 | 0 |
| 13 | 2020 | 50 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 66 | |
| 16 | 2020 | 14 | |
| 17 | 2020 | 19 | |
| 18 | 2019 | 1 | |
| 19 | 2016 | 1 | |
| 20 | Fingerprint of Eucommia ulmoides Oliv. processing product by HPLC | 2009 | 1 |
About Peng Song
Peng Song is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 93 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (11 papers), Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (553 citations), Cancer Research (224 citations) and Pulmonary and Respiratory Medicine (449 citations). Peng Song has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Shugeng Gao, Li Zhang, Xiaoxia Cui, Robert T. Kennedy, Shugeng Gao, Jianming Ying, Jie He, Fenglong Bie, Bolun Zhou and Guangyu Bai. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.